87.26 Down -0.79 -0.90%
Find StockScouter ratings for:
CHEMED CORPORATION (NEW): STOCK RATING SUMMARY
6
StockScouter

CHEMED CORPORATION (NEW), a small-cap value company in the health care sector, is expected to match the market over the next six months with less than average risk.

10 is the best possible rating.

QUICK SUMMARY
Pro

The StockScouter measure of relative price change and consistency is very high. Very positive

Con

The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative

One or more analysts has modestly decreased quarterly earnings estimates for CHE. Negative

FUNDAMENTAL
Grade: D

The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative

Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative

One or more analysts has modestly decreased quarterly earnings estimates for CHE. Negative

OWNERSHIP
Grade: D

Two or more executives, directors or major shareholders sold a small number of shares recently. Negative

Institutional holdings information is unavailable or inconsistent.

VALUATION
Grade: C

The price-to-earnings multiple is close to the average for all stocks in the StockScouter universe. Neutral

Price-to-sales information is unavailable or inconsistent.

The ratio of CHE's price-to-earnings multiple to its five-year growth rate is above the average of all stocks in the StockScouter universe. Negative

TECHNICAL
Grade: B

The StockScouter measure of relative price change and consistency is very high. Very positive

Previous day's closing price for CHE was close to its 50-day moving average. Neutral

StockScouter data provided by Verus Analytics

Verus Analytics, Inc.

Learn more about the StockScouter rating system.

Page generated 4/20/2014 3:12 AM ET

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.